Jacob A. Orville is VP at EXACT SCIENCES CORP (EXAS). They have made 11 open-market trades across 1 company since 2020, most recently 2026-03-23.
CIK 0001263312
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EXAS | SELL · 10b5-1 | 2025-11-19 | 2025-11-21 | $75.00 | $375K | +0.2% | +0.9% | +2.3% |
| EXAS | SELL · 10b5-1 | 2024-05-01 | 2024-05-02 | $60.15 | $6K | -13.6% | -28.3% | -26.9% |
| EXAS | SELL · 10b5-1 | 2024-03-01 | 2024-03-04 | $59.32 | $256K | +0.1% | +24.5% | -23.4% |
| EXAS | SELL · 10b5-1 | 2024-02-27 | 2024-02-28 | $56.89 | $214K | +6.4% | +23.4% | -17.6% |
| EXAS | SELL · 10b5-1 | 2024-02-22 | 2024-02-23 | $59.78 | $121K | -1.3% | +11.8% | -5.2% |
| EXAS | SELL · 10b5-1 | 2024-02-21 | 2024-02-22 | $61.50 | $66K | -2.1% | +6.7% | -10.5% |
| EXAS | SELL · 10b5-1 | 2024-02-15 | 2024-02-16 | $61.43 | $119K | -4.1% | -1.9% | -13.4% |
| EXAS | SELL · 10b5-1 | 2023-05-10 | 2023-05-12 | $80.00 | $400K | +3.8% | +14.7% | +3.9% |
| EXAS | SELL | 2023-03-03 | 2023-03-07 | $65.00 | $325K | -3.2% | +1.2% | +29.6% |
| EXAS | SELL | 2023-02-28 | 2023-03-01 | $60.46 | $524K | +3.6% | +10.6% | +32.3% |
| EXAS | SELL | 2023-02-22 | 2023-02-23 | $62.72 | $340K | +10.0% | +11.2% | +37.3% |
| EXAS | SELL | 2023-02-15 | 2023-02-16 | $69.59 | $133K | -0.1% | +1.5% | +25.8% |
| EXAS | SELL | 2022-02-24 | 2022-02-25 | $70.10 | $661K | -8.2% | -13.8% | -36.7% |
| EXAS | SELL | 2022-02-23 | 2022-02-24 | $69.05 | $155K | -4.8% | -9.9% | -35.7% |
| EXAS | SELL | 2022-02-22 | 2022-02-23 | $72.72 | $254K | +7.3% | +0.7% | -27.7% |
| EXAS | SELL | 2022-02-15 | 2022-02-16 | $79.55 | $75K | -1.1% | -13.4% | -30.0% |
| EXAS | SELL | 2021-02-19 | 2021-02-22 | $143.38 | $486K | -11.3% | -4.5% | -19.8% |
| EXAS | SELL | 2021-02-17 | 2021-02-18 | $142.66 | $295K | -5.2% | -6.0% | -32.7% |
| EXAS | SELL | 2020-02-19 | 2020-02-20 | $100.68 | $232K | -29.8% | -53.8% | -16.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.